UC Riverside Tool Tracks How Inflammation Starts
A modified chemotherapy compound targets mitochondrial DNA in lab-grown human airway cells to reveal early inflammatory triggers.
Updated on Nov. 18, 2026 in Life Sciences

University of California, Riverside researchers have developed a tool that tracks how inflammation begins in human cells. The work, published in Free Radical Biology and Medicine, used a modified version of the chemotherapy drug chlorambucil to damage DNA inside mitochondria in lab-grown airway cells.
Why it matters
Some pollutants and medicines damage DNA by leaving small chemical groups attached to its building blocks, and many chemicals harm both mitochondrial and nuclear DNA, which makes it hard to tell which damage triggers a response. A tool that targets mitochondrial DNA alone could help separate those effects and clarify how inflammation is set in motion.
The study compared a lower and a higher dose of the modified compound, with the lower dose leaving oxygen consumption normal and the higher dose producing abnormal mitochondrial behavior. Whether these laboratory thresholds apply in living human airways has not been tested.
The players
University of California, Riverside
A public research university in Riverside, California, part of the University of California system, where the inflammation-tracking tool was developed.
The details
Researchers added a chemical group to chlorambucil to help it collect in mitochondria, the structures that carry their own DNA separate from the nucleus. In lab-grown human airway cells, the modified tool damaged mitochondrial DNA, and the damaged DNA was found in the fluid outside the mitochondria.
Timeline
The study was published in Free Radical Biology and Medicine, and News-medical.net reported on it on November 18, 2026.
The Big Picture
Earlier DNA-damaging chemicals hit both mitochondrial and nuclear DNA, which blurred the cause of cellular inflammation. This work offers a way to isolate the mitochondrial contribution in a single experimental system.
The tool is currently a laboratory method, so it does not yet offer any treatment or test for patients. Its near-term value is for researchers studying how pollutants and medicines damage cells before inflammation sets in.
The takeaway
Separating mitochondrial from nuclear DNA damage is a practical step toward understanding how environmental chemicals and medicines trigger inflammation. Researchers plan to test molecules that cause different amounts of damage to refine that picture.
Further reading
Explore more research on Life Sciences to see how cell biology studies like this one fit into the broader field.
More information
Read the original Free Radical Biology and Medicine study on mitochondrial inflammation for the full methods and results.
Source note: This article includes information reported by News-Medical.






